Published in Arch Dis Child on February 01, 1993
DiGeorge syndrome: part of CATCH 22. J Med Genet (1993) 4.30
Isolation of a new marker and conserved sequences close to the DiGeorge syndrome marker HP500 (D22S134). J Med Genet (1993) 1.08
Features of DiGeorge syndrome and CHARGE association in five patients. J Med Genet (1997) 0.97
Noonan syndrome. J Med Genet (1987) 3.70
The spectrum of the DiGeorge syndrome. J Pediatr (1979) 3.24
Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics (1991) 2.80
Noonan syndrome: a review. Am J Med Genet (1985) 2.40
A clinical study of Noonan syndrome. Arch Dis Child (1992) 2.07
Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol (1986) 2.06
Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet (1992) 1.72
Localization of 27 DNA markers to the region of human chromosome 22q11-pter deleted in patients with the DiGeorge syndrome and duplicated in the der22 syndrome. Genomics (1990) 1.05
The Noonan syndrome. Eur Heart J (1983) 1.02
Partial deficiency of coagulation factor XI as a newly recognized feature of Noonan syndrome. J Pediatr (1983) 0.88
Interstitial deletions in DiGeorge syndrome detected with microclones from 22q11. Mamm Genome (1992) 0.86
Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus. J Med Genet (1992) 0.83
Noonan syndrome: partial factor XI deficiency. Am J Med Genet (1988) 0.81
Prenatal sonographic documentation of cystic hygroma regression in Noonan syndrome. Am J Med Genet (1991) 0.80
[Noonan's syndrome and its cardiovascular dysplasia. Apropos of 64 cases]. Pediatrie (1989) 0.80
A case of Noonan's syndrome and hypoparathyroidism presenting with epilepsy. J Neurol Neurosurg Psychiatry (1974) 0.80
Noonan and Klinefelter syndromes in a child. Am J Med Genet (1987) 0.80
A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands. Nature (1987) 7.88
Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature (1985) 7.77
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science (2001) 5.22
Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (2001) 4.41
Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07
Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet (1992) 3.45
Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr (2000) 3.35
Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet (2001) 3.28
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet (1993) 2.93
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70
Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet (1999) 2.41
Genomic imprinting in an Angelman and Prader-Willi translocation family. Lancet (1991) 2.41
Isolation of a further anonymous informative DNA sequence from chromosome seven closely linked to cystic fibrosis. Nucleic Acids Res (1986) 2.34
Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29
Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet (2000) 2.28
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny. Dev Biol (1997) 2.16
Physical and genetic analysis of cosmids from the vicinity of the cystic fibrosis locus. Nucleic Acids Res (1987) 2.16
Chromosome mediated gene transfer of six DNA markers linked to the cystic fibrosis locus on human chromosome seven. Nucleic Acids Res (1986) 2.16
Linkage of COL1A2 collagen gene to cystic fibrosis, and its clinical implications. Lancet (1985) 2.14
Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet (1998) 2.14
Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy (2008) 2.12
Effects of a few food diet in attention deficit disorder. Arch Dis Child (1993) 2.12
Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11
Comment on antigen-reduced infant formulae. ESPGAN Committee on Nutrition. Acta Paediatr (1993) 2.04
Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99
Dilutional hyponatremia during endoscopic curettage: the "female TURP syndrome"? Anesth Analg (1994) 1.98
Examining the validity of pressure ulcer risk assessment scales: developing and using illustrated patient simulations to collect the data. J Clin Nurs (2001) 1.95
Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Q J Med (1989) 1.88
Parents' responses to predictive genetic testing in their children: report of a single case study. J Med Genet (1996) 1.83
Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci U S A (1997) 1.78
Transition to adult services for children and young people with palliative care needs: a systematic review. Arch Dis Child (2009) 1.73
Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype. J Med Genet (1993) 1.71
Isolation of a human gene with protein sequence similarity to human and murine int-1 and the Drosophila segment polarity mutant wingless. EMBO J (1988) 1.67
Examination of fetuses after induced abortion for fetal abnormality. BMJ (1990) 1.66
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. Antimicrob Agents Chemother (1995) 1.64
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.62
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res (1984) 1.60
Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization. Genomics (1993) 1.55
Hypomelanosis of Ito: a manifestation of mosaicism or chimerism. J Med Genet (1988) 1.54
Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica. Cancer (1998) 1.54
Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature (1985) 1.51
Phenelzine in phobic anxiety: a controlled trial. Psychol Med (1973) 1.51
Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr (1998) 1.50
Low-copy-number repeat sequences flank the DiGeorge/velo-cardio-facial syndrome loci at 22q11. Hum Mol Genet (1993) 1.50
Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet (1995) 1.49
Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut (1984) 1.49
Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. Genomics (1991) 1.48
The reproductive biology of the New Zealand flora. Trends Ecol Evol (1993) 1.47
DiGeorge syndrome with isolated aortic coarctation and isolated ventricular septal defect in three sibs with a 22q11 deletion of maternal origin. Br Heart J (1991) 1.46
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45
Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci (1996) 1.42
The cycling of combination antirheumatic drug therapy in rheumatoid arthritis. Br J Rheumatol (1990) 1.41
p97 and close encounters of every kind: a brief review. Biochem Soc Trans (2004) 1.40
Characterisation of a short interspersed repeat (Mermaid) that has family members on human chromosome 21 and elsewhere in the human genome. Hum Genet (1996) 1.39
Trauma in cirrhosis: an indicator of the pattern of alcohol abuse in different societies. Alcohol Clin Exp Res (1991) 1.38
Folding of maltose-binding protein. Evidence for the identity of the rate-determining step in vivo and in vitro. J Biol Chem (1993) 1.37
Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet (2000) 1.36
Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol (1998) 1.33
Identification of a high-risk group for sudden infant death syndrome among infants who were resuscitated for sleep apnea. Pediatrics (1986) 1.33
Crash helmets reduce head injuries. Med J Aust (1973) 1.31
HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Nat Genet (1998) 1.31
Is intensive care justified for infants weighing less than 801 gm at birth? J Pediatr (1981) 1.31
Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome. Am J Hum Genet (1996) 1.31
The neurochemical and metabolic cascade following brain injury: moving from animal models to man. J Neurotrauma (1995) 1.30
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet (1998) 1.27
Human HOX gene mutations. Clin Genet (2001) 1.26
Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci (2000) 1.26
Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ (1999) 1.26
New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. Am J Hum Genet (1995) 1.25
Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut (2003) 1.24
Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect Immun (1991) 1.20
The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17
Wolf-Hirschhorn locus is distal to D4S10 on short arm of chromosome 4. J Med Genet (1987) 1.17
Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J Med Genet (1999) 1.16
Protection against oral and gastrointestinal diseases: importance of dietary nitrate intake, oral nitrate reduction and enterosalivary nitrate circulation. Comp Biochem Physiol A Physiol (1997) 1.16
Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet (1998) 1.15
Molecular study of 33 families with Fraser syndrome new data and mutation review. Am J Med Genet A (2008) 1.15
Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg (1993) 1.14
Isolation, characterization, and differential expression of the murine Sox-2 promoter. Gene (2000) 1.13
Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum Mol Genet (1999) 1.13
The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res (2002) 1.13
Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis. J Epidemiol Community Health (2002) 1.12
The structural gene for human coagulation factor X is located on chromosome 13q34. Cytogenet Cell Genet (1985) 1.12
Partial intestinal obstruction induces substantial mucosal proliferation in the pig. J Pediatr Surg (1996) 1.12
Left ventricular function in acute myocardial infarction evaluation by gated scintiphotography. Circulation (1974) 1.11